Moran Amit: Can Intralesional Nivolumab Help Prevent Oral Cancer?
Moran Amit/LinkedIn

Moran Amit: Can Intralesional Nivolumab Help Prevent Oral Cancer?

Moran Amit, Co-Director of the Neuroscience Program at UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Assistant Professor at MD Anderson Cancer Center, shared on LinkedIn:

“Pushing immunotherapy into the prevention space!

Come see us at Immunõ 2026: Global Virtual Congress on Immuno Oncology, Saturday, September 26, 2026.

Intralesional Nivolumab in Oral Dysplasia: A New Approach to Cancer Immunoprevention.”

Read more.”

Other articles featuring Moran Amit on Oncoaily.